Müller C - Search Results

1

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.

Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck-Radosavljevic M. Sieghart W, et al. Among authors: muller c. Hepatology. 2013 Jun;57(6):2261-73. doi: 10.1002/hep.26256. Epub 2013 May 3. Hepatology. 2013. PMID: 23316013

2

Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial.

Pinter M, Wichlas M, Schmid K, Plank C, Müller C, Wrba F, Peck-Radosavljevic M. Pinter M, et al. Among authors: muller c. Eur J Gastroenterol Hepatol. 2008 Oct;20(10):1012-9. doi: 10.1097/MEG.0b013e3283036740. Eur J Gastroenterol Hepatol. 2008. PMID: 18787470 Clinical Trial.

3

Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

Hucke F, Sieghart W, Schöniger-Hekele M, Peck-Radosavljevic M, Müller C. Hucke F, et al. Among authors: muller c. Wien Klin Wochenschr. 2011 Sep;123(17-18):542-51. doi: 10.1007/s00508-011-0033-9. Epub 2011 Jul 29. Wien Klin Wochenschr. 2011. PMID: 21800047

4

Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.

Peck-Radosavljevic M, Sieghart W, Kölblinger C, Reiter M, Schindl M, Ulbrich G, Steininger R, Müller C, Stauber R, Schöniger-Hekele M, Gschwendtner M, Plank C, Funovics M, Graziadei I, Lammer J, Gruenberger T, Gastl G, Karnel F; Austrian Association of Gastroenterology,Hepatology (ÖGGH); Austrian Society of Interventional Radiology (ÖGIR); Austrian Society of Hematology and Oncology (ÖGHO); Austrian Society for Surgical Oncology (ASSO). Peck-Radosavljevic M, et al. Among authors: muller c. Wien Klin Wochenschr. 2012 Feb;124(3-4):104-10. doi: 10.1007/s00508-011-0056-2. Epub 2011 Sep 22. Wien Klin Wochenschr. 2012. PMID: 21935644

5

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study.

Sieghart W, Pinter M, Reisegger M, Müller C, Ba-Ssalamah A, Lammer J, Peck-Radosavljevic M. Sieghart W, et al. Among authors: muller c. Eur Radiol. 2012 Jun;22(6):1214-23. doi: 10.1007/s00330-011-2368-z. Epub 2012 Jan 4. Eur Radiol. 2012. PMID: 22215073 Clinical Trial.

6

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C, Peck-Radosavljevic M, Sieghart W. Pinter M, et al. Among authors: muller c. Radiology. 2012 May;263(2):590-9. doi: 10.1148/radiol.12111550. Epub 2012 Mar 21. Radiology. 2012. PMID: 22438359

7

Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.

Sieghart W, Pinter M, Hucke F, Graziadei I, Schöniger-Hekele M, Müller C, Vogel W, Trauner M, Peck-Radosavljevic M. Sieghart W, et al. Among authors: muller c. Hepatology. 2013 Jun;57(6):2224-34. doi: 10.1002/hep.26057. Epub 2013 Jan 18. Hepatology. 2013. PMID: 22961713

8

The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.

Hucke F, Sieghart W, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M. Hucke F, et al. Among authors: muller c. J Hepatol. 2014 Jan;60(1):118-26. doi: 10.1016/j.jhep.2013.08.022. Epub 2013 Sep 3. J Hepatol. 2014. PMID: 24012941 Free article.

9

How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.

Hucke F, Pinter M, Graziadei I, Bota S, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M, Sieghart W. Hucke F, et al. Among authors: muller c. J Hepatol. 2014 Dec;61(6):1287-96. doi: 10.1016/j.jhep.2014.07.002. Epub 2014 Jul 10. J Hepatol. 2014. PMID: 25016222

10

Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.

Pinter M, Ulbrich G, Sieghart W, Kölblinger C, Reiberger T, Li S, Ferlitsch A, Müller C, Lammer J, Peck-Radosavljevic M. Pinter M, et al. Among authors: muller c. Radiology. 2015 Dec;277(3):903-12. doi: 10.1148/radiol.2015142140. Epub 2015 Jul 1. Radiology. 2015. PMID: 26131911 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,521 results

Search Page

Filters